Global Health Partnerships: The Pharmaceutical Industry and BRICA

by Mei-Ling Wang

Overview

The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never been more urgent. The decrease of profits in pharmaceutical markets in developed countries, the increasing pressure of price controls from regulations, the rapid increase of epidemics, pandemics, and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India, China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnership model between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.

Product Details

ISBN-13:	9780230265936
Publisher:	Palgrave Macmillan
Publication date:	11/28/2008
Sold by:	Barnes & Noble
Format:	eBook
File size:	244 KB

About the Author

MEI LING WANG is Associate Professor of Social Sciences and Health Policy at the University of the Sciences in Philidelphia, USA. She studied at the Harvard School of Public Health and has devoted her career to writing on global issues.

SHUO ZHANG works for DSS VHA, in Texas, USA and has been at the frontline of China's health system.

XIAO-WAN WANG is Professor of Health Economics at the school of Public Health, Central South University, China. He has first hand experience of working in China's health system as an academic and policy analyst.

Table of Contents

Acknowledgments ix

1 Global Health Partnerships: An Introduction 1

Global health challenges 1

Solutions: types and components 10

Major issues in global pharmaceutical provision 12

Pharmaceutical research and development 15

Global demand.for Pharmaceuticals 29

2 The Modern Pharmaceutical Industry: History, Current Position and Challenges 33

Drug development 34

The history of large pharmaceutical companies 36

Regulatory environment 38

Pharmaceutical companies 43

Large pharmas and R&D 50

Large pharmas' profit profile 57

Outsiders' perception of the pharmaceutical sector 62

Challenges facing the multinational pharmaceutical industry 73

Summary 78

3 BRICA in Global Pharmaceutical Provision 81

BRICA: The emerging economic powers 81

Economic prowess 86

BRICA's Pharmaceutical Industry 94

4 Global Health Partnerships between Multinationals and BRICA: A Planting Strategy 133

Planting strategy versus plucking strategy 134

The promise of planting 135

Innovation 135

Cost control 138

Quality control 142

Collaboration against counterfeits 147

The fundamental solution 153

Division of labor 161

Conclusion 163

References 167

Index 189